论文部分内容阅读
目的探讨分析阿奇霉素联合布地奈德雾化吸入治疗小儿肺炎支原体肺炎的临床疗效。方法回顾性分析2009年1月至2012年4月间在本院进行治疗的116例肺炎支原体肺炎患儿的临床记录资料。结果经过治疗,治疗组总有效率为91.38%,显著高于对照组的77.59%,差异具有统计学意义(P<0.05);治疗组的住院时间、退热时间均明显少于对照组,差异具有统计学意义(P<0.01)。结论阿奇霉素联合布地奈德雾化吸入治疗小儿肺炎支原体肺炎的临床疗效显著,具有推广价值。
Objective To investigate the clinical efficacy of azithromycin combined with budesonide inhalation in the treatment of children with Mycoplasma pneumoniae pneumonia. Methods The clinical records of 116 children with Mycoplasma pneumoniae pneumonia treated in our hospital from January 2009 to April 2012 were retrospectively analyzed. Results After treatment, the total effective rate of the treatment group was 91.38%, which was significantly higher than that of the control group (77.59%), the difference was statistically significant (P <0.05); The hospitalization time and antipyretic time of the treatment group were significantly less than those of the control group With statistical significance (P <0.01). Conclusion Azithromycin combined with budesonide inhalation therapy for children with Mycoplasma pneumoniae pneumonia clinical efficacy was significant, with the promotion of value.